abstract |
Disclosed herein are compounds of formula (I), methods of using the compounds to inhibit HPK1 activity, and pharmaceutical compositions comprising the compounds. The compounds are useful in the treatment, prevention or amelioration of diseases or conditions associated with HPKl activity, such as cancer. |